Navigation Links
Tissue loss triggers regeneration in planarian flatworms
Date:9/2/2013

r Scientist and an associate professor of biology at Massachusetts Institute of Technology. "It's one of the dream phenotypesto have a defect that's regeneration-specific, where the neoblasts are working. It's just regeneration that isn't working."

Such a phenotype could be a powerful tool in the further exploration of mechanisms that control regeneration. And many questions about these mechanisms remain.

"For example, the animals know how far to grow in regeneration, so they don't make tumorous outgrowths," says Wenemoser, who is now a postdoctoral researcher at Stanford University. "There's some kind of regulation on homeostatic size, so they're not growing out all wild and crazy. There's definitely more to investigate there."

Gavio agrees, and points out that the fst/act-1/2 switch may ultimately help scientists tease apart regeneration in other organisms, including humans.

"This regulation by activin and follistatin may be conserved in other systems," says Gavio, who is currently a postdoctoral researcher at Univeristy of California, San Francisco. "There are a lot of hints in the scientific literature that versions of activin or follistatin or both are activated by injury and may play a role in regeneration in other animals, but pinning the role of initiating regeneration to them hasn't happened yet."


'/>"/>

Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Fetal tissue-derived stem cells may be ideal source for repairing tissues and organs
2. New protocol developed to decontaminate human fetal tissues used for cell transplantation
3. Ovarian cancer metastases influenced by factors in target tissues
4. Bacterial DNA may integrate into human genome more readily in tumor tissue
5. Improved material for laser welding of tissue in intestinal surgery
6. Building better blood vessels could advance tissue engineering
7. Even mild traumatic brain injuries can kill brain tissue
8. Molecular basis identified for tissue specific immune regulation in the eye and kidney
9. Stem cell-based bioartificial tissues and organs
10. UT Arlington bioengineer to use hybrid imaging system to see deep tissue
11. UT Arlington engineer wins NSF award to support microfluidic analyses of tissue, cell samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... Service and the Southern Group of State Foresters released the ... Tuesday, May 17, which identifies areas forest managers will focus ... According to the report, urbanization, bioenergy use, weather patterns, ... South,s forests between the years 2010 and 2060. About ...
... be nutritional powerhouses, but some types are no match ... "mummy berry" disease. Fortunately, U.S. Department of Agriculture ... in blueberry breeding and cultivation. Geneticist Mark Ehlenfeldt and ... They work for USDA,s Agricultural Research Service (ARS). ...
... have been reviewing the family-group names in several major ... works is to provide a foundation of valid, accepted ... taxa, facilitate decisions on priority, promote long-term stability of ... transition of taxonomy into the digital age. A ...
Cached Biology News:Forest Service unveils first comprehensive forecast on southern forests 2Forest Service unveils first comprehensive forecast on southern forests 3
(Date:4/1/2015)... 2015  Adaptive Biotechnologies today announced publication of ... Oncology showing that analysis of circulating tumor ... residual disease (MRD) detection and quantification technology (available ... patients with diffuse large B-cell lymphoma (DLBCL) who ... usually several months before disease can be detected ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 ... (AFM) was selected to receive the prestigious “Best ... Economy Magazine.    Park NX10 is the premium research-grade True ... Z scanner linearity, closed-loop detector noise, and minimized ... SmartSca n, which allows images with a ...
(Date:4/1/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... to announce that Biohaven Pharmaceutical Holding Company Limited ... into an agreement with inVentiv Health for the ... their lead compound (BHV-0223). Biohaven ... clinical stage neuroscience compounds targeting the glutamatergic system. ...
(Date:4/1/2015)... 2015  Among 1,050 U.S. consumers, the majority knows ... percent) and only 36 percent reported being screened for ... findings from a survey released today by  ... developer of solutions that aid in the early detection ... polled 1,050 U.S. consumers on their knowledge of risk ...
Breaking Biology Technology:Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 2Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 3Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 4Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 5Park Systems Awarded the New Economy Magazine “Best Analytic Instrumentation Company 2014” 2Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 2National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 4
... and OMX Nordic Exchange: EPCT) today announced that ... be presenting at the IBC conference,on Assays and ... San Diego, CA,on October 17, 2007. Dr. Drewe ... discovery efforts targeting the Myc oncogene pathway,utilizing EpiCept,s ...
... NEW YORK, Oct. 15 Senex Biotechnology, Inc. ... at the 8th International,Conference on Alzheimer,s Disease Drug ... of Senex, described the identification of the first,drug ... amounts of,several proteins involved in Alzheimer,s disease, including: ...
... Therapeutics, Inc.,has named Jeffrey N. Fellows, a biotechnology ... regulatory experience, as Vice President,of Regulatory Affairs. ... PhD, said,"Jeff is a great addition to our ... clinical trials applications, regulatory compliance and,interactions with the ...
Cached Biology Technology:EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 2EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 3EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 4EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 5Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 3Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs 2